California Public Employees Retirement System’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.1M | Sell |
|
|||||
|
2025
Q2 | $40.3M | Sell |
|
|||||
|
2025
Q1 | $59.1M | Sell |
|
|||||
|
2024
Q4 | $55.9M | Sell |
|
|||||
|
2024
Q3 | $59.9M | Sell |
|
|||||
|
2024
Q2 | $73.3M | Sell |
|
|||||
|
2024
Q1 | $96.5M | Sell |
|
|||||
|
2023
Q4 | $111M | Sell |
|
|||||
|
2023
Q3 | $103M | Sell |
|
|||||
|
2023
Q2 | $101M | Sell |
|
|||||
|
2023
Q1 | $115M | Sell |
|
|||||
|
2022
Q4 | $128M | Sell |
|
|||||
|
2022
Q3 | $112M | Sell |
|
|||||
|
2022
Q2 | $110M | Sell |
|
|||||
|
2022
Q1 | $105M | Sell |
|
|||||
|
2021
Q4 | $123M | Sell |
|
|||||
|
2021
Q3 | $109M | Buy |
|
|||||
|
2021
Q2 | $108M | Buy |
|
|||||
|
2021
Q1 | $69.7M | Sell |
|
|||||
|
2020
Q4 | $82M | Buy |
|
|||||
|
2020
Q3 | $69.2M | Buy |
|
|||||
|
2020
Q2 | $100M | Buy |
|
|||||
|
2020
Q1 | $33.9M | Sell |
|
|||||
|
2019
Q4 | $35.9M | Buy |
|
|||||
|
2019
Q3 | $23.5M | Buy |
|
|||||
|
2019
Q2 | $23.2M | Sell |
|
|||||
|
2019
Q1 | $25M | Buy |
|
|||||
|
2018
Q4 | $21.4M | Sell |
|
|||||
|
2018
Q3 | $26.7M | Sell |
|
|||||
|
2018
Q2 | $28.2M | Sell |
|
|||||
|
2018
Q1 | $28.1M | Sell |
|
|||||
|
2017
Q4 | $32.3M | Buy |
|
|||||
|
2017
Q3 | $30.9M | Buy |
|
|||||
|
2017
Q2 | $29.7M | Buy |
|
|||||
|
2017
Q1 | $28.1M | Sell |
|
|||||
|
2016
Q4 | $27.7M | Sell |
|
|||||
|
2016
Q3 | $32.5M | Buy |
|
|||||
|
2016
Q2 | $27M | Sell |
|
|||||
|
2016
Q1 | $29.6M | Sell |
|
|||||
|
2015
Q4 | $38.6M | Buy |
|
|||||
|
2015
Q3 | $38.8M | Hold |
|
|||||
|
2015
Q2 | $50.4M | Buy |
|
|||||
|
2015
Q1 | $30.9M | Hold |
|
|||||
|
2014
Q4 | $30.9M | Buy |
|
|||||
|
2014
Q3 | $21.6M | Sell |
|
|||||
|
2014
Q2 | $20.1M | Sell |
|
|||||
|
2014
Q1 | $20.4M | Buy |
|
|||||
|
2013
Q4 | $21.7M | Sell |
|
|||||
|
2013
Q3 | $24.1M | Sell |
|
|||||
|
2013
Q2 | $19M | Buy |
|